Eli Lilly raises forecasts on surging international demand for weight-loss drugs

By Mrinalika Roy and Mariam Sunny (Reuters) -Eli Lilly raised its full-year profit and revenue forecasts on Thursday as strong international demand for weight-loss drugs helped it breeze past Wall Street's third-quarter earnings expectations. Shares of the world's largest healthcare company by market value jumped over 5% in premarket trading even as investors remain wary of drug price negotiations with the Trump administration. Lilly competes with Novo Nordisk for dominance in the weight-loss drug marke ...